SCHEMBL6289743

SCHEMBL6289743

Nc1ccccc1Oc1cccc(Oc2cccc(Oc3ccccc3Oc3ccccc3Oc3ccccc3Oc3cccc(Oc4cccc(Oc5ccccc5N)c4)c3)c2)c1

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.68
ALDH1A1 P00352 3/20 0.68
RCE1 Q9Y256 1/20 0.61
MAPT P10636 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
MEN1 O00255 2/20 0.50
KMT2A Q03164 2/20 0.50
MITF O75030 1/20 0.50
GFER P55789 1/20 0.50
NLRP1 Q9C000 1/20 0.50
NOD2 Q9HC29 1/20 0.50
TLR4 O00206 1/20 0.49
MAOB P27338 1/20 0.48
KDM4E B2RXH2 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6293929 1.00 GAA (0.68) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6289870 0.98 ALDH1A1 (0.70) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6293773 0.98 ALDH1A1 (0.70) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6290498 0.98 ALDH1A1 (0.70) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL1270032 0.98 ALDH1A1 (0.70) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6289265 0.96 ALDH1A1 (0.64) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6290489 0.96 ALDH1A1 (0.64) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6290163 0.96 ALDH1A1 (0.64) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6290631 0.96 ALDH1A1 (0.64) GAAALDH1A1RCE1MAPTSMN1; SMN2
SCHEMBL6289271 0.96 ALDH1A1 (0.64) GAAALDH1A1RCE1MAPTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6933411-B2 Aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2005-08-23 US disclosed
US-6737503-B2 LOW TEMPERATURE ADHESIVE BONDING MITSUI CHEMICALS, INC. (JP) 2004-05-18 US disclosed
US-20040082754-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2004-04-29 US disclosed
US-20030092870-A1 Novel aromatic diamine and polyimide thereof MITSUI CHEMICALS, INC. (JP) 2003-05-15 US disclosed
EP-1288191-A2 Novel aromatic diamine and polyimide thereof Mitsui Chemicals, Inc. (JP) 2003-03-05 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030092870-A1 Novel aromatic diamine and polyimide thereof DDT, AOC1, H1-4 GAA 4623/4885ALDH1A1 902/4885RCE1 3842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.